Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 21 studies | 39% ± 13% | |
type I pneumocyte | 11 studies | 35% ± 14% | |
epithelial cell | 10 studies | 35% ± 13% | |
secretory cell | 7 studies | 33% ± 10% | |
respiratory goblet cell | 5 studies | 23% ± 9% | |
ciliated cell | 5 studies | 31% ± 6% | |
goblet cell | 5 studies | 21% ± 7% | |
hillock cell | 3 studies | 27% ± 9% | |
squamous epithelial cell | 3 studies | 45% ± 20% | |
club cell | 3 studies | 21% ± 4% | |
enterocyte | 3 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 97% | 4283.11 | 562 / 578 | 94% | 333.34 | 1085 / 1155 |
stomach | 72% | 4069.30 | 257 / 359 | 93% | 138.91 | 266 / 286 |
intestine | 43% | 2277.29 | 413 / 966 | 96% | 154.93 | 508 / 527 |
esophagus | 38% | 2749.58 | 556 / 1445 | 98% | 364.77 | 179 / 183 |
bladder | 52% | 3194.71 | 11 / 21 | 82% | 215.87 | 413 / 504 |
breast | 86% | 3906.42 | 397 / 459 | 37% | 42.55 | 411 / 1118 |
prostate | 89% | 4725.31 | 219 / 245 | 34% | 27.02 | 169 / 502 |
skin | 90% | 5163.11 | 1636 / 1809 | 22% | 23.62 | 102 / 472 |
pancreas | 15% | 202.82 | 50 / 328 | 91% | 414.15 | 162 / 178 |
adrenal gland | 96% | 2600.09 | 248 / 258 | 5% | 4.13 | 12 / 230 |
tonsil | 0% | 0 | 0 / 0 | 98% | 445.86 | 44 / 45 |
uterus | 4% | 138.72 | 7 / 170 | 77% | 310.47 | 353 / 459 |
thymus | 8% | 74.40 | 50 / 653 | 63% | 117.17 | 384 / 605 |
kidney | 56% | 1572.98 | 50 / 89 | 15% | 19.58 | 132 / 901 |
liver | 44% | 704.57 | 100 / 226 | 17% | 30.94 | 67 / 406 |
adipose | 59% | 1247.13 | 711 / 1204 | 0% | 0 | 0 / 0 |
ovary | 4% | 41.36 | 7 / 180 | 53% | 43.59 | 227 / 430 |
heart | 13% | 124.89 | 113 / 861 | 0% | 0 | 0 / 0 |
muscle | 12% | 156.62 | 100 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 11% | 164.23 | 104 / 929 | 0% | 0 | 0 / 0 |
brain | 10% | 95.65 | 263 / 2642 | 0% | 0.20 | 3 / 705 |
blood vessel | 8% | 83.68 | 108 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.69 | 1 / 80 |
spleen | 0% | 3.50 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035987 | Biological process | endodermal cell differentiation |
GO_0050873 | Biological process | brown fat cell differentiation |
GO_0008544 | Biological process | epidermis development |
GO_0007155 | Biological process | cell adhesion |
GO_0005610 | Cellular component | laminin-5 complex |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0005515 | Molecular function | protein binding |
GO_0005198 | Molecular function | structural molecule activity |
Gene name | LAMB3 |
Protein name | Laminin beta 3 isoform 1 Laminin subunit beta 3 Laminin beta 3 isoform 2 Laminin subunit beta-3 (Epiligrin subunit bata) (Kalinin B1 chain) (Kalinin subunit beta) (Laminin B1k chain) (Laminin-5 subunit beta) (Nicein subunit beta) |
Synonyms | LAMNB1 |
Description | FUNCTION: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. |
Accessions | ENST00000415782.1 A0A0S2Z3R6 Q13751 Q5THA1 ENST00000455193.1 ENST00000391911.5 ENST00000356082.9 ENST00000367030.7 X1WI29 A0A0S2Z3Z3 |